F658 in Nebraska. Pick another state for the same tag.
Against expectation — 2025
Nebraska cites F658 less often than its own record predicts
Versus expected share0.16×
0.16 times the national share — cited less often here than elsewhere.
Share of Nebraska citations0.29%
Of every deficiency written in Nebraska in 2025, this is the portion that was F658.
Nebraska0.29%
National1.78%
Share of all citations that were F658.
Each state is measured against its own expected share, not against other states.
In the surveyor’s words
What Nebraska surveyors wrote
F658 findings written in Nebraska, one from each severity band recorded here, most serious first.
Severity is as the surveyor wrote it. Some findings had already been corrected before the survey.
D · No harm, potential for more than minimal, isolatedMay 27, 2026
Licensure Reference Number 175 NAC 12-006.10Based on observation, record review, and interview the facility failed staff failed to administer insulin per manufacturer direction for 2 residents (Resident 10 and Resident 6) of 2 sampled residents. The facility census was 23.Findings are:A.Record review of a document titled Injection FlexPen dated 02/2023 revealed to keep the needle in the skin for at least 6 seconds keeping the push button pressed all the way to ensure that the full dose of insulin has been administered. In an observation completed on 05/21/2026 from 11:05 AM through 11:30 AM the following was observed during insulin administration by Registered Nurse A (RN)-A the following was observed:A. …
Deficiency Index is independent and is not affiliated with, endorsed by, or approved by CMS, Medicare, or any government agency. About this data · Report a correction